Latest Partnerships News

Page 2 of 727
FBR has cut its annual loss dramatically and moved its first Mantis welding robot into commissioning, but year-end cash of just A$27,814 leaves the company dependent on fundraising, tax funding and successful delivery. Its audited accounts flag a material uncertainty over whether the robotics developer can continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026
International Graphite has moved its graphite processing strategy from plans towards construction and joint ventures, but the FY2026 annual report shows the company remains loss-making and reliant on external funding. Collie is scheduled for building completion in Q2 2027, while the proposed European hub still requires financing and development work.
Victor Sage
Victor Sage
30 Sept 2026
Pure Resources finished 2026 with $3.67 million in cash and no debt after raising $4.7 million, but its annual loss widened as it shifted from explorer to a Garnet Hills-led advanced materials platform. The company is now pursuing garnet abrasives, jumbo flake graphite and heavy rare earth recovery through US research and defence partnerships.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Noronex Limited (ASX:NRX) swung to a A$1.145 million statutory profit in FY2026, but the result was driven mainly by tenement disposal gains while operating cash outflows increased sharply. The auditor also highlighted material uncertainty over the explorer’s ability to continue without further funding.
Maxwell Dee
Maxwell Dee
30 Sept 2026
MC Mining has warned of a material uncertainty over its ability to continue as a going concern, despite its flagship Makhado project entering hot commissioning. The company ended FY2026 with US$2.904 million in cash, a US$49.746 million net current liability position and continued reliance on shareholder funding.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Decidr AI Industries delivered 99% revenue growth and a A$13.6 million annualised exit rate in FY26, but the company’s A$32.4 million loss and auditor-highlighted going concern uncertainty put funding at the centre of its next chapter. Management is targeting A$5 million in annualised savings while seeking to convert early AI deployments into recurring revenue.
Victor Sage
Victor Sage
30 Sept 2026
EcoGraf’s underwritten share purchase plan raised $3.552 million, well above its $2 million target, after shareholders applied for the full oversubscription. The result gives the company additional funding while leaving the final issue price and dilution to be confirmed.
Victor Sage
Victor Sage
30 Sept 2026
Eureka Group Holdings delivered FY26 underlying earnings ahead of guidance as its all-age rental portfolio expanded rapidly, but statutory profit fell and borrowings more than doubled. The next test is whether acquisitions, development and new capital partnerships can convert scale into durable cash returns.
Eva Park
Eva Park
30 Sept 2026
Javelin Minerals is pursuing an all-scrip takeover by FirstAU after its planned Eureka production partnership with MEGA Resources was terminated over regional processing constraints. The company reported a $2.69 million FY2026 loss, $3.92 million in cash and an auditor warning that further funding is required.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Conico's statutory loss widened sharply in FY2026, largely because of non-cash share-based payments linked to its recapitalisation. The company ended the year debt free with $2.53 million in cash, but warned that funding remains critical as it prepares for Mt Thirsty drilling.
Maxwell Dee
Maxwell Dee
30 Sept 2026
H3 Energy has consolidated ownership of its Alinya hydrogen and helium project and reframed Warro as a potential commercial gas development, but its annual report warns that funding remains critical. The company ended FY2026 with A$900,434 in cash, net liabilities of A$551,671 and a material uncertainty over its ability to continue as a going concern.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Vitrafy has added US blood network Versiti to its cryopreservation development programme, with the partnership focused on no-wash platelet preservation and regulatory verification. The deal strengthens the company’s institutional network, but initially generates no revenue and remains subject to US regulatory requirements.
Victor Sage
Victor Sage
30 Sept 2026

Browse the archive

Full archive